Literature DB >> 3145780

Sodium valproate decreases synaptic potentiation and epileptiform activity in hippocampus.

W H Griffith1, L Taylor.   

Abstract

The actions of sodium valproate (NaVP) were studied in the in vitro hippocampus using extracellular, intracellular and voltage-clamp recording techniques. In the CA1 region, concentrations of 30-200 microM NaVP reduced the amplitude but not the time course of post-tetanic potentiation (PTP) of dendritic field excitatory postsynaptic potentials (EPSPs). Epileptiform discharges were studied intracellularly in CA3 cells after pharmacological blockade of synaptic inhibition and repeated tetanic stimulation. NaVP (100 microM) blocked evoked paroxysmal depolarizing shift (PDS) discharges through a mechanism of increasing the threshold for burst-firing. When the PDS current was studied under voltage-clamp, application of NaVP (100 microM) resulted in a graded reduction of the PDS waveform. All of the actions of NaVP may result from inhibition of excitatory synaptic transmission following repetitive cell firing. A hypothesis is proposed that NaVP may act to decrease excitatory synaptic potentiation necessary for network synchronization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145780     DOI: 10.1016/0006-8993(88)90678-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture.

Authors:  C Zona; M Avoli
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

3.  Diphenytoin, riluzole and lidocaine: three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity.

Authors:  Lihong Diao; Jennifer L Hellier; Jessica Uskert-Newsom; Philip A Williams; Kevin J Staley; Audrey S Yee
Journal:  Neuropharmacology       Date:  2013-05-21       Impact factor: 5.250

4.  Animal models for the development of new neuropharmacological therapeutics in the status epilepticus.

Authors:  Ed Martín; Ma Pozo
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

5.  Impairment in social interaction and hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in a prenatal valproic acid-induced rat model of autism.

Authors:  Reihaneh Mohammadkhani; Reza Ghahremani; Iraj Salehi; Samaneh Safari; Seyed Asaad Karimi; Mohammad Zarei
Journal:  Brain Commun       Date:  2022-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.